Up and Over the Hurdles: Challenges and Controversies in Cardiology

Dr. Melanie Carter, BScPharm, ACPR, PharmD

Clinical Pharmacy Specialist—Cardiology Kelowna General Hospital, Interior Health

This will be an update on new evidence and therapies in cardiology focusing on the SPRINT trial and sacubitril/ valsartan (Entresto). Time will also be spent addressing the clinical controversy of duration of ACE-I/ARB and BB therapy after acute coronary syndrome.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s